Company Filing History:
Years Active: 2022
Title: Innovations by Niranjana Pokharel
Introduction
Niranjana Pokharel is an accomplished inventor based in Brighton, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic compounds. With a total of 2 patents, his work focuses on the inhibition of specific factors that contribute to cancer progression.
Latest Patents
Niranjana's latest patents include "Quinolin-2(1H)-one inhibitors of Late SV40 Factor" and "Heterocyclic LSF inhibitors and their uses." The first patent is directed towards compositions, methods, and kits for the treatment of cancer, specifically hepatocellular carcinoma (HCC). This invention discloses the use of small-molecule compounds to inhibit tubulin acetylation, thereby inhibiting cell migration and modulating cell compaction. The second patent focuses on heterocyclic SV40 Factor (LSF) inhibitors, detailing small-molecule compounds that can be used in methods for inhibiting LSF and treating cancer in subjects.
Career Highlights
Niranjana Pokharel is affiliated with Boston University, where he conducts his research and development. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to advancing medical science.
Collaborations
Niranjana collaborates with notable colleagues, including Scott Edward Schaus and Ulla Hansen, who contribute to his research efforts and enhance the scope of his projects.
Conclusion
Niranjana Pokharel's innovative work in cancer treatment through his patented inventions highlights his commitment to improving healthcare outcomes. His contributions are paving the way for new therapeutic approaches in the fight against cancer.